Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade...

Area of Science:

• Immunology
• Oncology
• Gastroenterology

Background:

• Intrahepatic cholangiocarcinoma (ICC) presents limited treatment options and poor prognosis.
• Current immunotherapies, like anti-programmed cell death protein (PD)-1, show low response rates in biliary tract cancers when combined with gemcitabine/cisplatin chemotherapy.

Purpose of the Study:

• To investigate the efficacy of combining anti-cytotoxic T lymphocyte antigen (CTLA)-4 with anti-PD-1 and gemcitabine/cisplatin in preclinical models of ICC.
• To elucidate the role of T cells and specific markers in the therapeutic response.

Main Methods:

• Utilized orthotopic murine models of aggressive ICC resistant to single-agent immunotherapy.
• Administered combination therapy including gemcitabine/cisplatin, anti-PD-1, and anti-CTLA-4.
• Assessed survival benefits, tumor burden, and characterized tumor-infiltrating lymphocytes, focusing on CD8+ T cells and Cxcr3 expression.

Main Results:

• Combination therapy significantly improved survival and reduced morbidity in aggressive ICC models.
• Gemcitabine/cisplatin enhanced tumor-infiltrating lymphocytes and normalized tumor vasculature, potentiating dual CTLA-4/PD-1 blockade.
• Activated CD8+Cxcr3+IFNγ+ T cells increased, and CD8+ T cells, along with Cxcr3 expression, were critical for therapeutic efficacy.
• Optimized scheduling of anti-CTLA-4 'priming' before chemotherapy followed by anti-PD-1 achieved similar efficacy with reduced drug exposure.

Conclusions:

• Dual blockade of CTLA-4 and PD-1 combined with chemotherapy offers substantial survival benefits in ICC models resistant to current therapies.
• CD8+ T cell activation and Cxcr3 expression are crucial mechanisms underlying the efficacy of this combination immunotherapy.
• Rational scheduling of immunotherapy and chemotherapy presents a promising strategy for improving ICC treatment outcomes and warrants clinical investigation.